Form 4 for ELV Elevance Health
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001156039-23-000025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-03 | 2023-03-01+ | ELV | Gallina John E | EVP, CFO | F - Tax | $468.81 | -5,237 | 63.7K | -8% | -$2.46M |
| DM | 2023-03-03 | 2023-03-01 | ELV | Gallina John E | EVP, CFO | A - Grant | $0.00 | +12.8K | 68.4K | +23% | $0 |
| D | 2023-03-03 | 2023-03-01 | ELV | Gallina John E | EVP, CFO | A - Grant | $0.00 | +11.8K | 11.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | F | D | 587 | $469.03 | 55,594 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 2 | Common | Common Stock | 2023-03-01 | A | A | 3,065 | $0.00 | 58,659 | D | — | — | (F2) Represents restricted share units. Restrictions lapse as follows: 1,021 shares on 3/1/2024, and 1,022 shares each on 3/1/2025 and 3/1/2026. |
| 3 | Common | Common Stock | 2023-03-01 | A | A | 9,716 | $0.00 | 68,375 | D | — | — | (F3) Represents performance based restricted share units. Restrictions lapse on 3/2/2023. |
| 4 | Common | Common Stock | 2023-03-02 | F | D | 4,650 | $468.78 | 63,725 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2023-03-01 | A | A | 11,782 | $0.00 | 11,782 | D | $469.03 · — to 2033-03-01 | 11,782 Common Stock | (F4) The option represents a right to purchase a total of 11,782 shares, and is exercisable in two installments of 3,927 shares each and one installment of 3,928 shares, beginning on 3/1/2024, which is the one-year anniversary of the option grant date. |